Journal for ImmunoTherapy of Cancer (Jul 2019)
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
- Davide Bedognetti,
- Michele Ceccarelli,
- Lorenzo Galluzzi,
- Rongze Lu,
- Karolina Palucka,
- Josue Samayoa,
- Stefani Spranger,
- Sarah Warren,
- Kwok-Kin Wong,
- Elad Ziv,
- Diego Chowell,
- Lisa M. Coussens,
- Daniel D. De Carvalho,
- David G. DeNardo,
- Jérôme Galon,
- Howard L. Kaufman,
- Tomas Kirchhoff,
- Michael T. Lotze,
- Jason J. Luke,
- Andy J. Minn,
- Katerina Politi,
- Leonard D. Shultz,
- Richard Simon,
- Vésteinn Thórsson,
- Joanne B. Weidhaas,
- Maria Libera Ascierto,
- Paolo Antonio Ascierto,
- James M. Barnes,
- Valentin Barsan,
- Praveen K. Bommareddy,
- Adrian Bot,
- Sarah E. Church,
- Gennaro Ciliberto,
- Andrea De Maria,
- Dobrin Draganov,
- Winson S. Ho,
- Heather M. McGee,
- Anne Monette,
- Joseph F. Murphy,
- Paola Nisticò,
- Wungki Park,
- Maulik Patel,
- Michael Quigley,
- Laszlo Radvanyi,
- Harry Raftopoulos,
- Nils-Petter Rudqvist,
- Alexandra Snyder,
- Randy F. Sweis,
- Sara Valpione,
- Roberta Zappasodi,
- Lisa H. Butterfield,
- Mary L. Disis,
- Bernard A. Fox,
- Alessandra Cesano,
- Francesco M. Marincola,
- Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Affiliations
- Davide Bedognetti
- Sidra Medicine
- Michele Ceccarelli
- AbbVie
- Lorenzo Galluzzi
- Department of Radiation Oncology, Weill Cornell Medical College
- Rongze Lu
- AbbVie
- Karolina Palucka
- The Jackson Laboratory for Genomic Medicine
- Josue Samayoa
- AbbVie
- Stefani Spranger
- Koch Institute for Integrative Cancer Research at MIT
- Sarah Warren
- NanoString Technologies, Inc
- Kwok-Kin Wong
- Perlmutter Cancer Center, New York Langone Health
- Elad Ziv
- University of California
- Diego Chowell
- Memorial Sloan Kettering Cancer Center
- Lisa M. Coussens
- Oregon Health & Science University
- Daniel D. De Carvalho
- Department of Medical Biophysics, Princess Margaret Cancer Centre University Health Network, University of Toronto
- David G. DeNardo
- Washington University School of Medicine in St. Louis
- Jérôme Galon
- INSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers
- Howard L. Kaufman
- Massachusetts General Hospital, Boston, MA, USA and Replimune, Inc
- Tomas Kirchhoff
- Perlmutter Comprehensive Cancer Center, New York University School of Medicine, New York University Langone Health New York
- Michael T. Lotze
- UPMC Hillman Cancer Center, University of Pittsburgh
- Jason J. Luke
- University of Chicago
- Andy J. Minn
- Abramson Family Cancer Research Institute, University of Pennsylvania
- Katerina Politi
- Yale School of Medicine
- Leonard D. Shultz
- The Jackson Laboratory Cancer Center
- Richard Simon
- R. Simon Consulting
- Vésteinn Thórsson
- Institute for Systems Biology
- Joanne B. Weidhaas
- University of California, Los Angeles
- Maria Libera Ascierto
- MedImmune
- Paolo Antonio Ascierto
- Istituto Nazionale Tumori-IRCCS Fondazione ‘G. Pascale’
- James M. Barnes
- AbbVie
- Valentin Barsan
- Stanford University
- Praveen K. Bommareddy
- Rutgers University
- Adrian Bot
- Kite, a Gilead Company
- Sarah E. Church
- NanoString Technologies, Inc
- Gennaro Ciliberto
- IRCCS Istituto Nazionale Tumori Regina Elena
- Andrea De Maria
- Università degli Studi di Genova and Ospedale Policlinico San Martino IRCCS
- Dobrin Draganov
- Calidi Biotherapeutics
- Winson S. Ho
- Department of Neurosurgery, Division of Pediatric Neurosurgery, Primary Children’s Hospital, University of Utah
- Heather M. McGee
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai
- Anne Monette
- Lady Davis Institute for Medical Research, Jewish General Hospital
- Joseph F. Murphy
- Caprion Biosciences Inc
- Paola Nisticò
- IRCCS Istituto Nazionale Tumori Regina Elena
- Wungki Park
- Memorial Sloan Kettering Cancer Center
- Maulik Patel
- AbbVie
- Michael Quigley
- Bristol-Myers Squibb Company
- Laszlo Radvanyi
- Ontario Institute for Cancer Research
- Harry Raftopoulos
- Bayer HealthCare Pharmaceuticals Inc
- Nils-Petter Rudqvist
- Department of Radiation Oncology, Weill Cornell Medical College
- Alexandra Snyder
- Merck & Co
- Randy F. Sweis
- University of Chicago
- Sara Valpione
- CRUK Manchester Institute and The Christie NHS Foundation Trust, The University of Manchester
- Roberta Zappasodi
- Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center
- Lisa H. Butterfield
- Parker Institute for Cancer Immunotherapy
- Mary L. Disis
- University of Washington
- Bernard A. Fox
- Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute
- Alessandra Cesano
- NanoString Technologies, Inc
- Francesco M. Marincola
- Refuge Biotechnologies Inc
- Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
- DOI
- https://doi.org/10.1186/s40425-019-0640-y
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 2
Abstract
Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.
